Topic: OR City:
Profile Page ›

FDA Approves 'Investigational New Drug'

FDA Approves 'Investigational Review Experience Z Y

Press release on FDA approval for Ethan Russo, MD, a neurologist in Missoula, Montana, to study the effects of smoked cannabis (marijuana) as compared to oral dronabinol (Marinol®) and injected sumatriptan (Imitrex®- the current 'gold standard') in the acute treatment of migraine.



Comment Feel free to add your comment or post!

Business Hours

Opening hours for FDA Approves 'Investigational New Drug' Application for Cannabis In Migraine Treatment ($) *

Reviews

FDA Approves 'Investigational New Drug' Application for Cannabis In Migraine Treatment FDA Approves 'Investigational New Drug' Application for Cannabis In Migraine Treatment Review › marijuananews.com/fda_approves_. Statistic generated on 2024-04-19
3 SiteBook.org Points
(According to Visits for this Profile)
http://sitebook.org/review-marijuananews.comfda_approves_.htm.png

Address

Website
Name
FDA Approves 'Investigational New Drug' Application for Cannabis In Migraine Treatment
Street  
ZIP Code
City
Region
State
Phone No.  

Z Y Conditions And Diseases Neurological Disorders Headaches Migraine Research

Reviews and Comments for FDA Approves 'Investigational New

Comment Feel free to add your comment or review!

Best entries for Z and Y

Review and Opening Hours Information

If the business hours of FDA Approves 'Investigational New Drug' Application for Cannabis In Migraine Treatment in may vary on holidays like Valentine’s Day, Washington’s Birthday, St. Patrick’s Day, Easter, Easter eve and Mother’s day. We display standard opening hours and price ranges in our profile site. We recommend to check out marijuananews.com/fda_approves_.htm for further information. You can also search for Alternatives for marijuananews.com/fda_approves_.htm on our Review Site Sitebook.org All trademarks are the property of their respective owners. If we should delete this entry, please send us a short E-Mail.

Our Recommendations: